Martin Shkreli, who became infamous after jacking up the price of a generic AIDs drug and boasting about it online, was arrested on securities fraud charges in December. Court documents allege that Shkreli ran Turing essentially like a Ponzi scheme: after losing considerable amounts of money for investors, he would lie about the losses and pull funds from his other companies to pay the debts.